Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 3Endocrine 3Sarcoma 1Gastrointestinal 1

Conditions

Sarcoma 11Osteosarcoma 4Gastrointestinal Stromal Tumors 3Gastrointestinal Neoplasms 3Central Nervous System Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Thyroid Neoplasms 2Oligodendroglioma 2Meningioma 2Melanoma 2Medulloblastoma 2Lymphoma 2Hemangiosarcoma 2Gliosarcoma 2Glioma 2Glioblastoma 2Ependymoma 2Brain Neoplasms 2Bone Neoplasms 2Astrocytoma 2Vulvar Neoplasms 1Vaginal Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Radiation Injuries 1Pyloric Stenosis, Hypertrophic 1Prostatic Neoplasms 1Plexosarcoma 1Pituitary Neoplasms 1

Interventions

Quality of Life 2Fluorodeoxyglucose F18 2tivozanib 1tislelizumab 1surufatinib 1romidepsin 1repotrectinib 1olaparib 1lutetium Lu 177 dotatate 1fludarabine phosphate 1fludarabine 1entrectinib 1atezolizumab 1amino-acid, glucose, and electrolyte solution 1alectinib 1Surveys and Questionnaires 1Poly(ADP-ribose) Polymerase Inhibitors 1Patient Reported Outcome Measures 1PM 01183 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Lactones 1Irinotecan 1Interleukin-2 1Immunotherapy 1FAPI-46 1Drug Therapy 1Depsipeptides 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroendocrine Tumors × Surveys and Questionnaires × Sarcoma × Clear all
NCT04077372 2023-01-27

Assessment of a Serious Illness Conversation Guide (SICG) in Advanced Gastro-Intestinal Cancers

Stanford University

Phase NA Terminated
12 enrolled
EndocrineGastrointestinalNETSarcoma

Esophageal Neoplasms, Gastrointestinal Neoplasms, Carcinoma, Hepatocellular, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡